Citius Pharmaceuticals Inc (NASDAQ:CTXR)

1.26
Delayed Data
As of 3:59pm ET
 +0.015 / +1.20%
Today’s Change
0.83
Today|||52-Week Range
2.25
-17.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization--1.3K2.6K1.8K
 
 
 
 
 
Operating ExpensesGross Income0.00-1.3K-2.6K-1.8K
 
 
 
 
General Expenses3.2M7.4M10.0M13.4M
 
 
 
 
 
Research And Development1.8M2.9M2.9M6.6M
 
 
 
 
 
Total Operating Expenses3.2M7.4M10.0M13.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-7.4M-10.0M-13.4M
 
 
 
 
 
Extraordinary Credit332.1K0.00452.1K450.0K
 
 
 
 
Extraordinary Charge0.00-838.2K0.00-357.4K
 
 
 
Interest Expense On Debt7.5K9.0K850.8K15.8K
 
 
 
 
 
Other Expenses0.000.000.00818.3K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.9M-8.3M-10.4M-12.5M
 
 
 
 
 
Net Income-2.9M-8.3M-10.4M-12.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.1M3.6M5.5M10.7M
 
 
 
 
 
Shares To Calculate EPS Diluted2.1M3.6M5.5M10.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.35-$2.25-$1.89-$1.17
 
 
 
 
 
EPS Diluted-$1.35-$2.25-$1.89-$1.17